Gyre Therapeutics Inc. GYRE
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Gyre Therapeutics Inc. is a biotechnology firm dedicated to the discovery and development of innovative therapies for unmet medical needs. Its primary function is to leverage cutting-edge research and development technologies to address complex diseases and conditions that currently lack effective treatments. Gyre Ther…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees579
TickerGYRE
Statistics
Market Cap$549.8M
Revenue (TTM)$116.6M
Net Income$9.9M
Net Margin8.5%
EPS$0.02
P/E364.50
P/S4.92
P/B5.35
EV/EBITDA106.53
ROE-3.1%
Dividend Yield—
Price$6.02
Data: Twelve Data · Revenue = mcap / P/S